HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO on BSE

This article was originally published in The Rose Sheet

Executive Summary

HHS Secretary Tommy Thompson should consider whether "food, cosmetics and OTC drugs should be labeled to advise consumers that the products may contain central nervous system tissue," according to a 1GAO report released Feb. 26 on U.S. regulatory efforts to prevent mad cow disease. "Consumers do not always know when foods and other products they use may contain central nervous system tissue, which, according to scientific experts, could pose a health risk if taken from diseased animals," GAO says. Report notes FDA is considering banning CNS tissue from foods, cosmetics, OTCs. GAO also recommends FDA, USDA strengthen animal feed ban enforcement, develop coordinated strategy to identify resources needed to increase import inspections...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel